MSP Recovery PE Ratio 2020-2024 | MSPR

Current and historical p/e ratio for MSP Recovery (MSPR) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MSP Recovery PE ratio as of May 01, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

MSP Recovery PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-02 1.90 0.00
2024-12-31 2.14 $-100.25 0.00
2024-09-30 0.15 $-142.50 0.00
2024-06-30 0.46 $-150.00 0.00
2024-03-31 0.69 $-156.50 0.00
2023-12-31 2.27 $-125.00 0.00
2023-09-30 5.37 $-82.75 0.00
2023-06-30 8.20 $-50.00 0.00
2023-03-31 21.25 $-62.50 0.00
2022-12-31 40.00 $-62.50 0.00
2022-09-30 30.00 $-62.50 0.00
2022-06-30 53.50 $-56.25 0.00
2022-03-31 256.50 0 0.00
2021-12-31 249.00 0 0.00
2021-09-30 247.75 0 0.00
Sector Industry Market Cap Revenue
Medical MEDICAL INFO SYS $0.016B $0.018B
MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) US $37.757B 52.15
Tempus AI (TEM) US $8.929B 0.00
Hims & Hers Health (HIMS) US $8.034B 129.14
Inspire Medical Systems (INSP) US $4.699B 91.27
IRhythm Technologies (IRTC) US $3.466B 0.00
Privia Health (PRVA) US $2.778B 208.18
Enovis (ENOV) US $1.976B 12.23
Schrodinger (SDGR) US $1.817B 0.00
Clover Health Investments (CLOV) US $1.696B 0.00
Phreesia (PHR) US $1.483B 0.00
Omnicell (OMCL) US $1.470B 31.70
Azenta (AZTA) US $1.199B 55.81
10x Genomics (TXG) US $0.991B 0.00
Butterfly Network (BFLY) US $0.568B 0.00
Fulgent Genetics (FLGT) US $0.532B 0.00
Talkspace (TALK) US $0.527B 313.00
Veradigm (MDRX) US $0.476B 0.00
Standard BioTools (LAB) US $0.422B 0.00
TruBridge (TBRG) US $0.390B 0.00
Claritev (CTEV) US $0.360B 0.00
Health Catalyst (HCAT) US $0.280B 0.00
Nyxoah SA (NYXH) BE $0.205B 0.00
SOPHiA GENETICS SA (SOPH) CH $0.201B 0.00
Pulmonx (LUNG) US $0.152B 0.00
American Well (AMWL) US $0.097B 0.00
EUDA Health Holdings (EUDA) SG $0.091B 0.00
Retrieve Medical Holdings (RMHI) US $0.085B 0.00
MDxHealth SA (MDXH) BE $0.082B 0.00
CareCloud (CCLD) US $0.075B 3.24
111 (YI) CN $0.071B 0.00
P3 Health Partners (PIII) US $0.064B 0.00
HeartBeam (BEAT) US $0.059B 0.00
Zepp Health (ZEPP) CN $0.041B 0.00
Outset Medical (OM) US $0.040B 0.00
Zhongchao (ZCMD) CN $0.029B 0.00
ImmunoPrecise Antibodies (IPA) CA $0.021B 0.00
Bullfrog AI Holdings (BFRG) US $0.017B 0.00
Streamline Health Solutions (STRM) US $0.013B 0.00
Healthcare Triangle (HCTI) US $0.012B 0.00
Strata Skin Sciences (SSKN) US $0.011B 0.00
Predictive Oncology (POAI) US $0.010B 0.00
Precipio (PRPO) US $0.010B 0.00
Movano (MOVE) US $0.006B 0.00
Mobile-health Network Solutions (MNDR) SG $0.004B 0.00
HeartSciences (HSCS) US $0.004B 0.00
Tivic Health Systems (TIVC) US $0.003B 0.00
Future Health ESG (FHLT) US $0.000B 0.00